View in EDS

PCN180 - The Cost-Effectiveness of Pegaspargase for First-Line Treatment of Acute Lymphoblastic Leukaemia: A Cost-Utility Analysis.

Saved in:

Bibliographic Details
Title:	PCN180 - The Cost-Effectiveness of Pegaspargase for First-Line Treatment of Acute Lymphoblastic Leukaemia: A Cost-Utility Analysis.
Authors:	Basu, S¹, Lin, PL², Saha, V³
Source:	Value in Health. Oct2017, Vol. 20 Issue 9, pA444-A444. 1p.
Database:	Academic Search Ultimate

Description
ISSN:	10983015
DOI:	10.1016/j.jval.2017.08.263